Twin Tree Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-513,621
Closed -$46.2M 1700
2024
Q3
$43.1M Buy
513,621
+250,692
+95% +$19.1M 0.08% 196
2024
Q2
$18M Buy
+262,929
New +$17.5M 0.04% 401
2024
Q1
Sell
-310,462
Closed -$23.9M 1408
2023
Q4
$25.2M Buy
+310,462
New +$24.2M 0.05% 396
2023
Q3
Sell
-124,076
Closed -$9.54M 1329
2023
Q2
$9.56M Sell
124,076
-19,141
-13% -$1.53M 0.01% 627
2023
Q1
$11.9M Sell
143,217
-175,125
-55% -$14.5M 0.02% 533
2022
Q4
$27.3M Buy
318,342
+213,174
+203% +$16.9M 0.06% 308
2022
Q3
$6.49M Sell
105,168
-62,130
-37% -$3.92M 0.01% 696
2022
Q2
$10.3M Buy
+167,298
New +$10.4M 0.02% 633
2022
Q1
Sell
-489,888
Closed -$31.3M 1724
2021
Q4
$35.6M Buy
489,888
+232,373
+90% +$16M 0.07% 249
2021
Q3
$18M Buy
257,515
+101,080
+65% +$7.1M 0.04% 393
2021
Q2
$10.8M Buy
156,435
+27,760
+22% +$1.85M 0.03% 492
2021
Q1
$8.32M Sell
128,675
-250,151
-66% -$16.1M 0.03% 505
2020
Q4
$22.1M Sell
378,826
-36,128
-9% -$2.18M 0.09% 256
2020
Q3
$26.2M Buy
414,954
+323,703
+355% +$22.4M 0.11% 206
2020
Q2
$7.02M Sell
91,251
-53,280
-37% -$4.08M 0.03% 555
2020
Q1
$10.8M Buy
144,531
+108,572
+302% +$7.5M 0.05% 310
2019
Q4
$2.34M Sell
35,959
-32,719
-48% -$2.13M 0.01% 684
2019
Q3
$4.35M Sell
68,678
-32,437
-32% -$2.12M 0.02% 513
2019
Q2
$6.83M Buy
+101,115
New +$6.65M 0.03% 381
2019
Q1
Sell
-14,956
Closed -$994K 1416
2018
Q4
$935K Sell
14,956
-22,138
-60% -$1.55M 0.01% 865
2018
Q3
$2.86M Sell
37,094
-21,722
-37% -$1.64M 0.02% 513
2018
Q2
$4.17M Sell
58,816
-21,710
-27% -$1.53M 0.03% 475
2018
Q1
$6.07M Buy
80,526
+76,648
+1,976% +$6.09M 0.05% 305
2017
Q4
$278K Sell
3,878
-59,030
-94% -$4.48M ﹤0.01% 867
2017
Q3
$5.1M Sell
62,908
-18,667
-23% -$1.43M 0.04% 369
2017
Q2
$5.77M Buy
81,575
+47,420
+139% +$3.16M 0.05% 355
2017
Q1
$2.32M Sell
34,155
-39,384
-54% -$2.77M 0.02% 522
2016
Q4
$5.27M Sell
73,539
-11,605
-14% -$863K 0.05% 385
2016
Q3
$6.74M Buy
85,144
+26,012
+44% +$2.11M 0.09% 226
2016
Q2
$4.93M Buy
59,132
+34,009
+135% +$3.02M 0.08% 260
2016
Q1
$2.31M Buy
25,123
+19,142
+320% +$1.73M 0.04% 385
2015
Q4
$605K Buy
+5,981
New +$622K 0.01% 807
2015
Q2
Sell
-14,702
Closed -$1.61M 1371
2015
Q1
$1.44M Sell
14,702
-11,154
-43% -$1.13M 0.04% 487
2014
Q4
$2.44M Sell
25,856
-15,033
-37% -$1.55M 0.07% 324
2014
Q3
$4.35M Buy
+40,889
New +$4M 0.12% 198
2014
Q2
Sell
-12,928
Closed -$1.01M 947
2014
Q1
$916K Buy
+12,928
New +$1.01M 0.02% 635
2013
Q4
Sell
-9,511
Closed -$662K 958
2013
Q3
$598K Buy
+9,511
New +$568K 0.02% 564

Other funds holding GILD

Twin Tree Management's GILD Position: Q4 2024 in Review

Twin Tree Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 513,621 shares — an estimated $46.2M sold.

Twin Tree Management first reported a position in GILD in Q3 2013 and held it in 37 quarters. The position peaked at $43.1M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Twin Tree Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Twin Tree Management sold 513,621 Gilead Sciences shares in Q4 2024, an estimated $46.2M.
  • Twin Tree Management first reported a position in Gilead Sciences in Q3 2013 and held it in 37 quarters.
  • Twin Tree Management's Gilead Sciences position peaked at $43.1M in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Twin Tree Management's 13F filing for Q4 2024, filed 10 Feb 2025.